Microadenoma vs Macroadenoma: What is the Size Difference?
At a Glance
A pituitary microadenoma is a tumor smaller than 1 centimeter (10 mm) across, while a macroadenoma is 1 centimeter or larger. This size difference is critical because larger tumors can press on optic nerves, causing vision loss, and may require surgery rather than simple monitoring.
If your MRI report uses the terms “microadenoma” or “macroadenoma,” it is simply describing the physical size of your non-functioning pituitary adenoma. The medical difference is straightforward: a microadenoma is defined as being less than 1 centimeter (10 millimeters) across, while a macroadenoma is 1 centimeter (10 millimeters) or larger [1][2]. (You may also occasionally see the term giant adenoma for tumors that are 4 centimeters/40 millimeters or larger). This size distinction is important because it directly influences whether the tumor is likely to cause symptoms and helps guide the choice between monitoring the tumor or removing it.
Why Size Matters for Symptoms
The pituitary gland sits in a small, bony pocket behind your nose called the sella turcica. Because this space is tight, the size of a tumor dictates whether it will press on surrounding structures.
- Microadenomas (< 1 cm): Because they are small, microadenomas rarely push against nearby nerves or brain tissue. For a non-functioning adenoma (one that doesn’t overproduce hormones), a microadenoma usually causes no symptoms and is often discovered by accident when an MRI is done for an unrelated reason.
- Macroadenomas (≥ 1 cm): As a tumor grows to 1 cm or larger, it can extend upward out of its bony pocket (suprasellar extension) [3] and stretch the surrounding tissue, which frequently causes headaches. Right above the pituitary gland sits the optic chiasm, the structure where your optic nerves cross. If a macroadenoma presses on the optic chiasm, it can cause visual field deficits (often a loss of peripheral vision) and general vision loss [4][5]. Additionally, larger adenomas can compress the healthy, normal tissue of the pituitary gland itself, causing hormone deficiencies (such as secondary adrenal insufficiency or central hypothyroidism) [6][7]. In daily life, these deficiencies can cause profound fatigue, unexplained weight changes, low blood pressure, or feeling constantly cold.
How Size Guides Treatment Decisions
Because non-functioning pituitary adenomas do not secrete excess hormones, treatment decisions are heavily based on the tumor’s size, its growth rate, and whether it is causing symptoms.
- Active Surveillance: For small microadenomas, and even some macroadenomas that are not pressing on the optic nerves, doctors often recommend active surveillance (or “watch and wait”) [8][9]. This involves scheduling regular MRI scans (often every 1 to 2 years, depending on the exact size) and eye exams to monitor for growth, as these tumors often grow very slowly or not at all [9].
- Surgical Removal: If a macroadenoma is compressing the optic nerves, causing vision loss, or threatening normal pituitary function, doctors will typically recommend surgery [10][11]. The most common approach is endoscopic transsphenoidal surgery, a minimally invasive procedure performed through the nose to remove the tumor and relieve pressure [10], usually requiring a short hospital stay. Preoperative imaging and visual assessments are used to evaluate how much the optic nerve is compressed, which helps predict visual recovery after surgery [12][13]. Advanced eye tests, like optical coherence tomography (OCT)—a non-invasive eye imaging test—can help doctors monitor the health of the optic nerve even before you notice vision changes [14][15].
Regardless of whether your tumor is a microadenoma or a macroadenoma, your care team will look at the whole picture—your MRI, your vision tests, and your hormone levels—to create a personalized plan.
Common questions in this guide
What size is considered a pituitary macroadenoma?
Can a pituitary microadenoma cause vision problems?
How does tumor size affect my treatment plan?
What are the signs that my pituitary tumor is growing?
What is a giant pituitary adenoma?
Questions to Ask Your Doctor
Curated prompts to bring to your next appointment.
- 1.What are the exact dimensions of my adenoma in millimeters?
- 2.Based on the size of my tumor, how much distance is there between it and my optic nerve?
- 3.Should I see a neuro-ophthalmologist for baseline visual field and OCT testing?
- 4.Given the size of my adenoma, do you recommend active surveillance, and if so, exactly how frequently will I need MRI scans?
- 5.Do I need blood testing to check if the tumor size is compressing my healthy pituitary tissue and affecting my normal hormone levels?
- 6.What specific vision or physical changes should prompt me to call your office immediately?
Questions For You
Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.
Related questions
References
References (15)
- 1
Non-functioning pituitary microadenoma in children and adolescents: Is follow-up with diagnostic imaging necessary?
Borghammar C, Tamaddon A, Erfurth EM, et al.
Endocrine 2023; (79(1)):152-160 doi:10.1007/s12020-022-03212-7.
PMID: 36251115 - 2
Subclinical acromegaly: to treat or not to treat?
Shimon I, Adnan Z, Hirsch D, et al.
Endocrine journal 2022; (69(11)):1323-1328 doi:10.1507/endocrj.EJ22-0066.
PMID: 35732439 - 3
Secondary Pituitary Abscess Inside a Macroadenoma Complicated by Postoperative Hemorrhage and Reinfection: A Case Report.
Krzemińska A, Czapiga B, Bladowska J, Koźba-Gosztyła M
The American journal of case reports 2025; (26()):e947794 doi:10.12659/AJCR.947794.
PMID: 40540450 - 4
Pituitary Macroadenoma Presenting With Monocular Temporal Hemianopia.
Gupta A, Deshmukh M, Palexas G
Journal of neuro-ophthalmology : the official journal of the North American Neuro-Ophthalmology Society 2021; (41(2)):e267-e268 doi:10.1097/WNO.0000000000001119.
PMID: 33136669 - 5
Clinical characteristics and ophthalmologic findings of pituitary adenoma in Korean patients.
Kim TG, Jin KH, Kang J
International ophthalmology 2019; (39(1)):21-31 doi:10.1007/s10792-017-0778-x.
PMID: 29274021 - 6
Baseline MRI findings as predictors of hypopituitarism in patients with non-functioning pituitary adenomas.
Al Argan R, Ramadhan A, Agnihotram RV, et al.
Endocrine connections 2021; (10(11)):1445-1454.
PMID: 34636742 - 7
Relationship of each anterior pituitary hormone deficiency to the size of non-functioning pituitary adenoma in the hospitalized patients.
Mukai K, Kitamura T, Tamada D, et al.
Endocrine journal 2016; (63(11)):965-976 doi:10.1507/endocrj.EJ16-0168.
PMID: 27534814 - 8
Prevalence, Clinical Features, and Natural History of Incidental Clinically Non-Functioning Pituitary Adenomas.
Iglesias P, Arcano K, Triviño V, et al.
Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme 2017; (49(9)):654-659 doi:10.1055/s-0043-115645.
PMID: 28759937 - 9
The natural history of non-functioning pituitary adenomas: A meta-analysis of conservatively managed tumors.
Pernik MN, Montgomery EY, Isa S, et al.
Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia 2022; (95()):134-141 doi:10.1016/j.jocn.2021.12.003.
PMID: 34929637 - 10
Insights into Visual Outcomes and Determinants in Pituitary Adenoma Surgery: A 5-Year Retrospective Cohort Study.
Kemchoknatee P, Singhakul C, Arjkongharn N, et al.
Clinical ophthalmology (Auckland, N.Z.) 2024; (18()):1779-1788 doi:10.2147/OPTH.S463303.
PMID: 38919405 - 11
A Meta-Analysis of Endoscopic vs. Microscopic Transsphenoidal Surgery for Non-functioning and Functioning Pituitary Adenomas: Comparisons of Efficacy and Safety.
Guo S, Wang Z, Kang X, et al.
Frontiers in neurology 2021; (12()):614382 doi:10.3389/fneur.2021.614382.
PMID: 33833725 - 12
Visual recovery following pituitary adenoma surgery: prognostic value of optical coherence tomography and suprasellar tumour volume.
Hayat ŞÇ, Yılmaz YC, Erkan B, et al.
Canadian journal of ophthalmology. Journal canadien d'ophtalmologie 2025; (60(3)):163-169 doi:10.1016/j.jcjo.2024.10.015.
PMID: 39532278 - 13
Preoperative volume of the optic chiasm is an easily obtained predictor for visual recovery of pituitary adenoma patients following endoscopic endonasal transsphenoidal surgery: a cohort study.
Zhang Y, Chen C, Huang W, et al.
International journal of surgery (London, England) 2023; (109(4)):896-904 doi:10.1097/JS9.0000000000000357.
PMID: 36999782 - 14
Segmented retinal analysis in pituitary adenoma with chiasmal compression: A prospective comparative study.
Agarwal R, Jain VK, Singh S, et al.
Indian journal of ophthalmology 2021; (69(9)):2378-2384 doi:10.4103/ijo.IJO_2086_20.
PMID: 34427226 - 15
Retinal nerve fiber layer thickness and its correlation with visual symptoms and radiological features in pituitary macroadenoma.
Menon S, Nair S, Kodnani A, et al.
Journal of neurosciences in rural practice 2023; (14(1)):41-47 doi:10.25259/JNRP_18_2022.
PMID: 36891116
This page explains pituitary adenoma size classifications for educational purposes only. Always consult your endocrinologist or neurosurgeon to interpret your specific MRI results and treatment options.
Get notified when new evidence is published on Non-functioning pituitary adenoma.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.